“Bio Studies of Novel Macrocyclic Sulfazan and Linear Sulfazan (Creation, Analysis and Anticancer Assessment)” (2022) Journal of Pharmaceutical Negative Results, 13(4), pp. 351–363. doi:10.47750/pnr.2022.13.04.043.